Rotavirus antigens
US4861864A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 13, 1988 |
| Grant date | Aug 29, 1989 |
| Priority date | — |
| Expiry date | Jun 13, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2720/12322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A soluble form of the neutralizing antigen or rotavirus is provided. The antigen is formed by cloning DNA coding for VP7 protein into an expression vector and preparing deletion mutants coding for a soluble cell secreted neutralizing antigen. The preparation of the deletion mutants includes the removal of the DNA sequences coding for those amino acids of the VP7 protein responsible for its normal intracellular location and non-secretion characteristics. The deletion mutant may be used in the formation of stably transformed animal cell lines which contiuously secrete the antigen, or in the production of certain yeast strains which produce the soluble antigen with appropriate glycosylation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.